LISATA THERAPEUTICS, INC. Available-for-sale Securities, Amortized Cost Basis
LISATA THERAPEUTICS, INC. (LSTA) had Available-for-sale Securities, Amortized Cost Basis of $42.33 million as of 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-05-10
- 2018-03-31: Available-for-sale Securities, Amortized Cost Basis $42.33M.
- 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $51.91M; Available-for-sale Securities, Amortized Cost Basis as first filed $51.91M.
- 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $56.27M.
- 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $55.83M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2018-03-31 | $42.33M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $51.91M 10-Q · filed 2018-05-10 | $51.91M 10-K · filed 2018-03-22 |
| 2017-09-30 | $56.27M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $55.83M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $1.43M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $4.43M 10-K · filed 2018-03-22 | |
| 2016-09-30 | $4.39M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $8.29M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $1.41M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $6.87M 10-K · filed 2017-03-17 | |
| 2015-09-30 | $18.42M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $28.32M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $14.51M 10-Q · filed 2015-05-06 | |
| 2014-12-31 | $22.36M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $18.48M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $28.38M 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |